Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg

The outbreak of the coronavirus disease 2019 (COVID-19) spread rapidly throughout the world during the first months of 2020 reaching the pandemic status as a major global health issue. The main clinical and therapeutic concerns due to COVID-19 relate to the respiratory distress and failure caused by pneumonia due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. COVID-19, however, is not just a pulmonary disease. While respiratory complications and systemic inflammation unquestionably result in significantly higher morbidity and mortality rates, cardiovascular complications are also common [2].

Source: Thrombosis Research - August 5, 2020 Category: Hematology Authors: Francesca Pizzolo, Anna Maria Rigoni, Sergio De Marchi, Simonetta Friso, Elisa Tinazzi, Giulia Sartori, Filippo Stefanoni, Francesca Nalin, Martina Montagnana, Sara Pilotto, Michele Milella, Anna Maria Azzini, Evelina Tacconelli, Giacomo Marchi, Domenico Tags: Letter to the Editors-in-Chief Source Type: research